Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

J Parma1, L Duprez, J Van Sande

  • 1Institut de Recherche Interdisciplinaire, Faculty of Medicine, University of Brussels, Belgium.

Nature
|October 14, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Both in vivo FSH depletion and follicular exposure to Gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice.

Molecular human reproduction·2018
Same author

Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.

Human reproduction (Oxford, England)·2015
Same author

AMH mutations with reduced in vitro bioactivity are related to premature ovarian insufficiency.

Human reproduction (Oxford, England)·2015
Same author

[Is ovarian function impaired in HIV patients? A clinical pilot study in Burkina Faso].

Revue medicale de Bruxelles·2013
Same author

Cloning of the TSH receptor: the story from a Brussels perspective.

Annales d'endocrinologie·2011
Same author

Variants of the BMP15 gene in a cohort of patients with premature ovarian failure.

Human reproduction (Oxford, England)·2010
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
See all related articles

Somatic mutations in the thyrotropin receptor cause hyperfunctioning thyroid adenomas. These genetic alterations lead to unregulated activation of the adenylyl cyclase-cAMP pathway, promoting thyroid growth and overactivity.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyrotropin (TSH) stimulates thyrocytes via cyclic AMP (cAMP) signaling.
  • Unregulated adenylyl cyclase-cAMP cascade activation can cause thyroid hyperplasia and hyperthyroidism.
  • Somatic mutations affecting G protein Gsa activity are implicated in some hyperfunctioning thyroid adenomas.

Purpose of the Study:

  • To investigate somatic mutations in the thyrotropin receptor in hyperfunctioning thyroid adenomas.
  • To determine if identified mutations lead to constitutive receptor activation.

Main Methods:

  • Analysis of eleven hyperfunctioning thyroid adenomas for somatic mutations.
  • Transfection of mutant thyrotropin receptors into COS cells.
  • Assessment of adenylyl cyclase activation in transfected cells.

Related Experiment Videos

Main Results:

  • Identified somatic mutations in the thyrotropin receptor's third cytoplasmic loop in 3 of 11 adenomas.
  • Mutations involved specific amino acid changes at positions 619 and 623.
  • Mutant receptors demonstrated constitutive activation of adenylyl cyclase in vitro.

Conclusions:

  • Somatic mutations in the thyrotropin receptor can cause hyperfunctioning thyroid adenomas.
  • These mutations lead to constitutive receptor activation, mimicking TSH stimulation.
  • G-protein-coupled receptors, like the TSH receptor, can act as proto-oncogenes when somatically mutated.